Generative AI and automation are revolutionising drug approval, enhancing compliance, efficiency, and speed in pharmaceutical processes, from discovery to regulatory reporting and patient safety.
HSCNI, Microsoft and Kainos on their world-beating response to the COVID-19 challenge.
Gilead Science’s PrEP Hub® platform is a gamechanger in the fight against HIV – both the disease and the stigma.
Innovating new ways to digitally transform refugees’ lives for the better
Automation and AI are reshaping medical billing by reducing errors, accelerating reimbursements, and streamlining workflows—helping modern practices improve efficiency, revenue cycles, and overall financial performance.
Heightened climate impacts prompt action, regulatory focus on greenwashing, climate technology adoption, and pivotal elections.
The public sector’s data practices must be fixed before it becomes a fast favourite for hackers, says Netwrix’s Ilia Sotnikov
Mary Jesse is CEO of MTI. In this podcast, Mary discusses the company’s diversity initiatives, how she broke down barriers early in her career, and why diversity is good business.
Moussa Zaghdoud is EVP for Alcatel-Lucent Enterprise’s Cloud Communications Business.
In this podcast, Moussa tells us why he has always wanted to build technology to help people.
Generative AI and automation are revolutionising drug approval, enhancing compliance, efficiency, and speed in pharmaceutical processes, from discovery to regulatory reporting and patient safety.
